Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

1781 - 1790 of 7311 results found

Cost-Effectiveness of the Second COVID-19 Booster Vaccination in the USA

Date
Wednesday, November 01, 2023 - 4:00 AM
Description
CONCLUSION: The second booster strategy was likely to be dominant in reducing the disease burden of the COVID-19 pandemic. Expanding the second booster strategy to ages 18-49 and 12-17 years would remain dominant due to their social contacts with the